Immuno-inflammatory and organ dysfunction markers in severe COVID-19 patients

被引:0
|
作者
Ahmed, Najat Jabbar [1 ]
Amin, Zahra A. [2 ]
Kheder, Ramiar Kamal [3 ,4 ]
Pirot, Rzgar Qadir [5 ]
Mutalib, Gulstan A. [1 ]
Jabbar, Sana Najat [1 ]
机构
[1] Erbil Polytech Univ, Erbil Tech Hlth & Med Coll, Dept Med Lab Technol, Erbil 44001, Iraq
[2] Hawler Med Univ, Coll Pharm, Dept Clin Anal, Erbil 44001, Iraq
[3] Univ Raparin, Coll Sci, Med Lab Sci Dept, Rania 46012, Sulaymaniyah, Iraq
[4] Tishk Int Univ, Fac Appl Sci, Dept Med Anal, Erbil, Iraq
[5] Univ Raparin, Coll Sci, Biol Dept, Rania 46012, Sulaymaniyah, Iraq
关键词
SARS CoV-2; Cytokine; Inflammation; Biomarkers; Body organs; COUNT;
D O I
10.1016/j.cyto.2024.156715
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection with the SARS-CoV-2 virus may induce some complications among people who experience mild to moderate respiratory illness and some of them recover without requiring special treatment. Albeit, some individuals become seriously reached risk points and require special medical attention especially older people and people who suffer from chronic diseases. Serum and whole blood samples were collected from confirmed infected persons with SARS CoV-2 by real-time PCR and the control group. All lab. Investigations were performed using Cobas 6000. Significant differences were noted between patients compared to the control group in the Mean f SD of IL-6 (76.06 f 7.60 vs 3.61 f 0.296 pg/ml), Procalcitonin (0.947 f 0.117 vs 0.061 f 0.007 ng/ml), CRP (125.3 f 7.560 vs 4.027 f 0.251 mg/dl), ALT (154.8 f 30.47 vs 49.75 f 2.977 IU/L) and AST (70.83 f 9.215 vs 27.23 f 1.767) respectively. While other parameters were also showed significant differences were noted between patients compared to the control group for D-Dimmer, PT, PTT, LDH, Ferritin, WBC, Lymphocyte and Creatinine. The results reached that the effect of SARS CoV-2 and cytokine storm was clear on the body's organs through vital biomarker investigations that were performed in this study.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] The First Comprehensive Evaluation of Immuno-Inflammatory Markers for Prognosis in Esophageal Cancer Patients: A South Asian Perspective
    Qureshi, Sajida
    Abbasi, Waqas Ahmad
    Jalil, Hira Abdul
    Mughal, Saba
    Quraishy, Muhammad Saeed
    CLINICS AND PRACTICE, 2024, 14 (05) : 2071 - 2079
  • [42] The role of the immuno-inflammatory response in patients after cardiac arrest
    Samborska-Sablik, Anna
    Sablik, Zbigniew
    Gaszynski, Wojciech
    ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (04) : 619 - 626
  • [43] Increased Activation Markers of Adaptive Immunity in Patients with Severe COVID-19
    Aljuaid, Abdulelah
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [44] Circulating markers of extracellular matrix remodelling in severe COVID-19 patients
    Murphy, Sarah Louise
    Halvorsen, Bente
    Holter, Jan Cato
    Huse, Camilla
    Tveita, Anders
    Troseid, Marius
    Hoel, Hedda
    Kildal, Anders Benjamin
    Holten, Aleksander Rygh
    Lerum, Tori Vigeland
    Skjonsberg, Ole Henning
    Michelsen, Annika E.
    Aalokken, Trond M.
    Tonby, Kristian
    Lind, Andreas
    Dudman, Susanne
    Granerud, Beathe Kiland
    Heggelund, Lars
    Boe, Simen
    Dyrholt-Riise, Anne Ma
    Aukrust, Pal
    Barratt-Due, Andreas
    Ueland, Thor
    Dahl, Tuva Borresdatter
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (06) : 784 - 797
  • [45] Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients
    Giron, Leila B.
    Dweep, Harsh
    Yin, Xiangfan
    Wang, Han
    Damra, Mohammad
    Goldman, Aaron R.
    Gorman, Nicole
    Palmer, Clovis S.
    Tang, Hsin-Yao
    Shaikh, Maliha W.
    Forsyth, Christopher B.
    Balk, Robert A.
    Zilberstein, Netanel F.
    Liu, Qin
    Kossenkov, Andrew
    Keshavarzian, Ali
    Landay, Alan
    Abdel-Mohsen, Mohamed
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
    Klinkhammer, Brent
    Go, Ronaldo
    Hollenberg, Steven
    Landers, David
    Turi, Zoltan
    Glotzer, Taya
    Jamal, Sameer
    Safi, Lucy
    Gayed, Noha
    Fata, Matthew
    Tancredi, Jana
    Gourna-Paleoudis, Elli
    Marafelias, Michael
    Nyirenda, Themba
    Haber, Spencer
    Jaten, Thomas
    Shah, Neel
    Shah, Roshan
    Parrillo, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3029 - 3029
  • [47] CAN INFLAMMATORY MARKERS PREDICT THE SUCCESSFUL EXTUBATION IN PATIENTS WITH COVID-19?
    Mughal, Mohsin
    Preet, Ikwinder
    Ali, Kaur
    Denise, Jaffery
    Dalmacion, Lauren
    Kramer, Violet
    Patton, Chandler
    Granet, Kenneth
    CHEST, 2020, 158 (04) : 600A - 600A
  • [48] Inflammatory markers and COVID-19 disease progression
    Sidhwani, Santosh Kumar
    Mirza, Talat
    Khatoon, Ambrina
    Shaikh, Fouzia
    Khan, Rizma
    Shaikh, Omer Ahmed
    Nashwan, Abdulqadir J.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (09) : 1386 - 1391
  • [49] Blood Inflammatory Markers and Cytokines in COVID-19 Patients With Bacterial Coinfections
    Bi, Qingqing
    Zhu, Jie
    Zheng, Jinju
    Xu, Qingyun
    Chen, Juan
    Zhang, Lei
    Mu, Xiaofeng
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (12)
  • [50] Olfactory Dysfunction in Mild-Moderate-Severe COVID-19 Patients
    Tuzun, Kemal
    Abes, Derya
    B-ENT, 2022, 18 (01) : 59 - 66